Journal
/
/
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
JoVE Journal
Bioengineering
This content is Free Access.
JoVE Journal Bioengineering
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
DOI:

10:44 min

May 05, 2023

, , , , , , ,

Chapters

  • 00:05Introduction
  • 01:34Engineering a Fluorescence-Based Reporter Cell Line
  • 03:10Designing gRNAs for CRISPR/dCas9-Based Epigenetic Silencing of Target Gene
  • 04:13Arrayed Transient Delivery of CRISPR/dCas9-Based ETRs in Reporter Cell Line
  • 07:19Analyzing Transcriptional Activity of Target Gene Over Time
  • 08:11Results: dCas9 ETR-Mediated Epigenetic Silencing of Human B2M Gene by gRNAs
  • 09:23Conclusion

Summary

Automatic Translation

Here, we present a protocol for the in vitro selection of engineered transcriptional repressors (ETRs) with high, long-term, stable, on-target silencing efficiency and low genome-wide, off-target activity. This workflow allows for reducing an initial, complex repertoire of candidate ETRs to a short list, suitable for further evaluation in therapeutically relevant settings.

Related Videos

Read Article